Raffaella Benedetti
A5044886040- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Cardiac Arrhythmias and Treatments
- Hormonal and reproductive studies
- Central Venous Catheters and Hemodialysis
- Orthopedic Surgery and Rehabilitation
- Diagnosis and Treatment of Venous Diseases
- Cardiac electrophysiology and arrhythmias
- Cardiac tumors and thrombi
- Blood Pressure and Hypertension Studies
- Urinary Bladder and Prostate Research
- Acute Myocardial Infarction Research
- Blood Coagulation and Thrombosis Mechanisms
- Sports Performance and Training
- Shoulder Injury and Treatment
- Pharmacovigilance and Adverse Drug Reactions
- Lipoproteins and Cardiovascular Health
- Muscle metabolism and nutrition
- Peripheral Nerve Disorders
- Body Composition Measurement Techniques
- Retinal and Optic Conditions
- Thermoregulation and physiological responses
- Vasculitis and related conditions
- Antiplatelet Therapy and Cardiovascular Diseases
- Pharmacology and Obesity Treatment
Ospedaliera di Piacenza
2013-2024
Laboratoire Lorrain de Recherche en Informatique et ses Applications
2023
University of Parma
1997-2000
Vita-Salute San Raffaele University
1997
University of St. Gallen
1995
Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, risk adverse Asian patients with AF, using data from a global prospective cohort study.From GLORIA-AF Registry Phase II-III (November 2011-December 2014 for II, January 2014-December 2016 III), we analysed according their self-reported ethnicity (Asian vs. non-Asian), as well subgroups (Chinese, Japanese,...
Abstract Background and purpose Prospectively collected data comparing the safety effectiveness of individual non-vitamin K antagonists (NOACs) are lacking. Our objective was to directly compare NOACs in patients with newly diagnosed atrial fibrillation (AF). Methods In GLORIA-AF, a large, prospective, global registry program, consecutive AF were followed for 3 years. The comparative analyses (1) dabigatran vs rivaroxaban or apixaban (2) performed on propensity score (PS)-matched patient...
Abstract Aims Chronic Obstructive Pulmonary Disease (COPD) may influence management and prognosis of Atrial Fibrillation (AF), but this relationship has been scarcely explored in contemporary global cohorts. We aimed to investigate the association between AF COPD, relation treatment patterns major outcomes. Methods From prospective, GLORIA-AF Registry, we analysed factors associated with COPD diagnosis, as well risk outcomes COPD. Primary outcome was composite all-cause death adverse...
OBJECTIVE: To assess if androgen decline in physiological aging contributes to the concomitant changes body composition and lipoprotein levels. DESIGN: Cross‐sectional, observational study. SETTING: A university‐based outpatient center. SUBJECTS: The study comprised 206 healthy volunteers (aged 18–95 years). MEASUREMENTS: Blood samples were drawn after an overnight fast for assay of hormones (free testosterone (FT), estradiol (E 2 ), sex hormone‐binding globulin (SHBG)) lipids (total...
Abstract The 2MACE score was specifically developed as a risk-stratification tool in atrial fibrillation (AF) to predict cardiovascular outcomes. We evaluated the predictive ability of GLORIA-AF registry. All eligible patients from phase II/III prospective global registry were included. Major adverse cardiac events (MACEs) defined composite outcome stroke, myocardial infarction and death. Cox proportional hazards used examine relationship between study Predictive capability investigated...
The SAMe-TT2R2 score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during vitamin K antagonists (VKA) and those scores >2 might be better managed a target-specific oral anticoagulant (NOAC). We hypothesized that in clinical practice, VKAs may prescribed less frequently AF than lower scores.We analyzed the Phase III dataset of Global Registry on Long-Term Oral Antithrombotic Treatment Patients Atrial Fibrillation (GLORIA-AF), large, global,...